Rare Gynaecological Cancers Appeal

Around 18% of all gynaeological cancers are defined as rare. Supported by CTRT, the RaNGO trial will collect an anonymised national registry of patients with these rare cancers to enable a pool of knowledge and treatment options across the UK.